Recruiting
Phase 2

Barzolvolimab

Sponsor:

Celldex Therapeutics

Code:

NCT06727552

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Barzolvolimab

Matching placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Celldex Therapeutics on 2025-05-20.